Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dna X (SONM) Other Gross PP&E Adjustments (2018 - 2025)

Dna X's Other Gross PP&E Adjustments history spans 8 years, with the latest figure at -$110000.0 for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$110000.0 for Q4 2025, down 117.92% from a year ago — trailing twelve months through Dec 2025 was -$110000.0 (down 117.92% YoY), and the annual figure for FY2025 was -$110000.0, down 117.92%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$110000.0 at Dna X, down from $614000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.3 million in Q4 2021 to a low of -$956000.0 in Q2 2022.
  • The 5-year median for Other Gross PP&E Adjustments is -$321000.0 (2023), against an average of $246545.5.
  • The sharpest move saw Other Gross PP&E Adjustments skyrocketed 6971.43% in 2023, then plummeted 117.92% in 2025.
  • Year by year, Other Gross PP&E Adjustments stood at $5.3 million in 2021, then plummeted by 100.13% to -$7000.0 in 2022, then skyrocketed by 6971.43% to $481000.0 in 2023, then grew by 27.65% to $614000.0 in 2024, then plummeted by 117.92% to -$110000.0 in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$110000.0, $614000.0, and $481000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.